StockData
Accendra Health Inc logo

Accendra Health Inc (ACH) stock

ACHNYSEWholesale-Medical, Dental & Hospital Equipment & SuppliesFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/3098% below fair value
$0.13−0.02 (-13.33%)

Close on Nov 13, 2026Market cap $10.00MP/E –Yield –

Earnings

Accendra Health's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 18, 2027
Q4 FY2026 · estimated, after the close
Revenue, Q2 FY2026
$613.20M
Adj. (loss) income from continuing operations, net of tax, per common share, Non-GAAP, Q2 FY2026
-$0.19
Latest guidance
Issued
Nov 5, 2026 · 1 item

Quarterly results

Revenue and earnings per share from each of Accendra Health's earnings releases, newest first

QuarterReportedRevenueYoYEPSAdj. EPSSource
Q4 FY2026ended Dec 31, 2026Feb 18, 2027Expected–––––
Q3 FY2026ended Sep 30, 2026Nov 5, 2026after the close––––Release
Q2 FY2026ended Jun 30, 2026Aug 10, 2026before the open$613.20M–-$1.16-$0.19Release
Q1 FY2026ended Mar 31, 2026May 11, 2026before the open––––Release
Q4 FY2025ended Dec 31, 2025Feb 19, 2026after the close––––Release
Q3 FY2025ended Sep 30, 2025Oct 30, 2025after the close––––Release
Q2 FY2025ended Jun 30, 2025Aug 11, 2025before the open––––Release
Q1 FY2025ended Mar 31, 2025May 8, 2025before the open––––Release
Q4 FY2024ended Dec 31, 2024Feb 28, 2025before the open––––Release
Q3 FY2024ended Sep 30, 2024Nov 4, 2024before the open––––Release
Q2 FY2024ended Jun 30, 2024Aug 2, 2024before the open$2.70B+5.5%-$0.42$0.36Release
Q1 FY2024ended Mar 31, 2024May 3, 2024before the open$2.60B+4.0%-$0.29$0.19Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Current guidance

Accendra Health's latest outlook for periods it has not reported yet, compared with what it said before

MetricPeriodGuidanceBeforeChangeGiven
net revenueFY2026$2.45B – $2.55B–NewNov 5, 2026
RevenueFY2026$2.45B – $2.55B$2.55B – $2.65BLoweredAug 10, 2026
Adjusted EBITDAnon-GAAPFY2026$300.00M – $320.00M$335.00M – $355.00MLoweredAug 10, 2026
Free cash flownon-GAAPFY2026$90.00M – $110.00M–NewFeb 19, 2026

Guidance history

Every forecast Accendra Health put in an earnings release, newest first

GivenMetricPeriodGuidanceChange
Nov 5, 2026net revenueFY2026$2.45B – $2.55BNew
Aug 10, 2026Adjusted EBITDAFY2026$300.00M – $320.00MLowered
Aug 10, 2026RevenueFY2026$2.45B – $2.55BLowered
Feb 19, 2026Adjusted EBITDAFY2026$335.00M – $355.00MNew
Feb 19, 2026Free cash flowFY2026$90.00M – $110.00MNew
Feb 19, 2026RevenueFY2026$2.55B – $2.65BNew
Oct 30, 2025Adjusted EBITDAFY2025$376.00M – $382.00MNew
Oct 30, 2025Adjusted EPSFY2025$1.02 – $1.07New
Oct 30, 2025RevenueFY2025$2.76B – $2.82BNew
May 8, 2025Adjusted EBITDAFY2025$560.00M – $590.00MReaffirmed
May 8, 2025Adjusted EPSFY2025$1.60 – $1.85Reaffirmed
May 8, 2025RevenueFY2025$10.85B – $11.15BReaffirmed
Feb 28, 2025Capital expenditures, grossFY2025$250.00M – $270.00MNew
Feb 28, 2025Adjusted EBITDAFY2025$560.00M – $590.00MNew
Feb 28, 2025Adjusted EPSFY2025$1.60 – $1.85New
Feb 28, 2025Gross marginFY202520.75% – 21.25%New
Feb 28, 2025Interest expenseFY2025$138.00M – $142.00MNew
Feb 28, 2025Diluted weighted average sharesFY202580New
Feb 28, 2025Adjusted effective tax rateFY202529% – 30%New
Feb 28, 2025RevenueFY2025$10.85B – $11.15BNew

Read from the company's earnings releases; each figure links to its sentence on hover. “Raised” and “Lowered” compare with the previous range for the same metric and period.

Press releases

Releases Accendra Health filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Update
  4. Update
  5. Update
  6. Update
  7. Update
  8. Update
  9. Results
  10. Results
  11. Update
  12. News
  13. News
  14. Update
  15. Update

See a number that looks wrong?